lycorine has been researched along with Cancer of Skin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, Y; Ma, J; Miao, F; Shen, C; Shen, M; Tai, Z; Xin, R; Zhu, Q | 1 |
| Jiang, QQ; Liu, WB | 1 |
| Bao, M; Cao, Z; Liu, R; Pan, Y; Shang, B; Tu, J; Yang, P; Zhang, G; Zhang, S; Zhou, Q | 1 |
3 other study(ies) available for lycorine and Cancer of Skin
| Article | Year |
|---|---|
Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cations; Cell-Penetrating Peptides; Mice; Mice, Nude; Skin Neoplasms | 2023 |
Lycorine inhibits melanoma A375 cell growth and metastasis through the inactivation of the PI3K/AKT signaling pathway.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Humans; Melanoma; Neoplasm Metastasis; Phenanthridines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Skin Neoplasms | 2018 |
Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry.
Topics: Amaryllidaceae Alkaloids; Animals; Antigens, CD; Cadherins; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Models, Biological; Neoplasm Metastasis; Neovascularization, Pathologic; Phenanthridines; Promoter Regions, Genetic; Skin Neoplasms | 2012 |